Brain metastases free survival differs between breast cancer subtypes-Reference-Cited by-同舟云学术

Brain metastases free survival differs between breast cancer subtypes

Published:2012-01 Issue:3 Volume:106 Page:440-446
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Berghoff A,Bago-Horvath Z,De Vries C,Dubsky P,Pluschnig U,Rudas M,Rottenfusser A,Knauer M,Eiter H,Fitzal F,Dieckmann K,Mader R M,Gnant M,Zielinski C C,Steger G G,Preusser M,Bartsch R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2011597.pdf

Reference31 articles.

1. Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117 (8): 1602–1611

2. Beslija S, Bonneterre J, Burstein H, Cocquyt V, Gnant M, Goodwin P, Heinemann V, Jassem J, Kostler WJ, Krainer M, Menard S, Petit T, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H (2007) Second consensus on medical treatment of metastatic breast cancer. Ann Oncol 18 (2): 215–225

3. Burstein HJ, Lieberman G, Slamon DJ, Winer EP, Klein P (2005) Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol 16 (11): 1772–1777

4. Cameron D, Casey M, Press M, Lindquist D, Pienkowski T, Romieu CG, Chan S, Jagiello-Cruszfeld A, Kaufman B, Crown J, Chan A, Campone M, Viens P, Davidson N, Gorbounova V, Raats JI, Skarlos D, Newstat B, Roychowdhury D, Paoletti P, Oliva C, Rubin S, Stein S, Geyer CE (2008) A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses. Breast Cancer Res Treat 112 (3): 533–543

5. Clayton AJ, Danson S, Jolly S, Ryder WD, Burt PA, Stewart AL, Wilkinson PM, Welch RS, Magee B, Wilson G, Howell A, Wardley AM (2004) Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 91 (4): 639–643

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients;Cancer Medicine;2024-06

2. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review;Breast Cancer Research;2024-03-29

3. The relationship between brain metastasis and HER2 expression status in gastric cancer;Clinical and Translational Oncology;2023-08-24

4. Factors improving overall survival in breast cancer patients with leptomeningeal disease (LMD): A single institutional retrospective review.;2023-06-08

5. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression;ESMO Open;2022-12